
News • Focus on tumor STAT1 acetylation
How cancer cells learn under pressure to evade immunotherapy
Immunotherapy has been hailed as a breakthrough in cancer treatment. But new research reveals: under sustained treatment pressure, cancer does not simply weaken — it adapts, learns, and fights back.


























































































